Progesterone Receptor
Progesterone receptor (PR) is a protein found inside cells, which is activated by the steroid hormone progesterone. In humans, PR is encoded by a single PGR gene residing on chromosome 11q22, it has two main forms, A and B, that differ in their molecular weight. Progesterone is necessary to induce the progesterone receptors. When no binding hormone is present the carboxyl terminal inhibits transcription. Binding to a hormone induces a structural change that removes the inhibitory action. Progesterone antagonists prevent the structural reconfiguration. After progesterone binds to the receptor, restructuring with dimerization follows and the complex enters the nucleus and binds to DNA. There transcription takes place, resulting in formation of messenger RNA that is translated by ribosomes to produce specific proteins. Progesterone receptor plays a central role in diverse reproductive events associated with establishment and maintenance of pregnancy, alveolar development in the breast and sexual behavior.
Targets for Progesterone Receptor
Products for Progesterone Receptor
- Cat.No. Product Name Information
-
GC68493
17α-Hydroxyprogesterone-d8
17α-Hydroxyprogesterone-d8 is the deuterated form of 17α-Hydroxyprogesterone. 17α-Hydroxyprogesterone (17-OHP) is an endogenous progestogen that serves as a chemical intermediate in the biosynthesis of other steroid hormones, including glucocorticoids, androgens, and estrogens.
- GC50394 AG 205 Progesterone receptor membrane component 1 (Pgrmc1) ligand
- GC13297 Altrenogest Progestogen receptor agonist
- GC35408 Asoprisnil Asoprisnil (J867), a selective progesterone receptor modulator, exhibits mixed progesterone agonist and antagonist effects on various progesterone targeted tissues in animal and human.
- GC11144 Chlormadinone acetate steroidal progestin with additional antiandrogen and antigonadotropic effects
- GC38648 Cridanimod Cridanimod is a potent progesterone receptor (PR) activator mediated through induction of IFNα and IFNβ expression.
- GC11964 Desogestrel progestin used in hormonal contraceptives
- GC15578 Dienogest Orally active synthetic progesterone
- GC12379 Drospirenone Synthetic progestin
- GC15409 Dydrogesterone Potent, orally active progestogen
- GC63706 Dydrogesterone-D6
- GC60815 Estradiol dipropionate Estradiol dipropionate is a combined estrogen-progesterone, acts as an estrogen and progesterone agonist.
- GC12000 Ethynodiol diacetate Progestogen receptor agonist
- GC10017 Gestodene Progestogen hormonal contraceptive
- GC34200 Gestonorone Capronate Gestonorone Capronate is a progestin for the treatment of benign prostatic hypertrophy and endometrial cancer.
- GC63751 Levonorgestrel-D8
-
GC12974
Medroxyprogesterone acetate
Steroidal progestin
- GC61850 Medroxyprogesterone acetate D3
- GC11688 Megestrol Acetate Anti-estrogen agent
- GC11637 Mifepristone Progesterone receptor antagonist
- GC17200 Nestoron A synthetic progestin
- GC36755 Nomegestrol acetate Nomegestrol acetate is an orally active, highly selective progestogen and a progesterone receptor complete agonist.
- GC10215 Norethindrone synthetic progestin
- GC36759 Norethindrone acetate Norethindrone acetate is a female hormone used for the research of endometriosis.
- GC63752 Norethindrone acetate-D8
- GC39654 Norethisterone enanthate Norethisterone enanthate is a long-acting parenteral progestogen.
- GC63143 PF-02413873 PF-02413873 (PF-2413873) is a potent selective, fully competitive and orally active nonsteroidal progesterone receptor (PR) antagonist, with a Ki of 2.6 nM.
- GC12408 Progesterone Progesterone
- GC16847 Tanaproget
- GC41153 Tibolone Tibolone is an estrogen-like compound used for the treatment of the symptoms associated with menopausal transition (i.e., climacteric symptoms) and also for the treatment of osteoporosis.
- GC17305 Ulipristal progestogen receptor modulator
- GC11677 Ulipristal acetate Novel selective progesterone receptor modulator (SPRM)